Miami Cardiac & Vascular Institute Grand Rounds Evaluation - April 19, 2017

As a result of participating in this course, to what extent do you agree that you will be better able to accomplish these objectives *

Scoring Key: 5=Strongly Agree 4=Agree 3=Neutral 2=Disagree 1=Strongly Disagree 0=Not applicable to my practice

	5	4	3	2	1	0
Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury.	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 5	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 4	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 3	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 2	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 1	Recognize specific cardiovascular conditions associated with the administration of cancer therapy, and implement surveillance measures for cardiac injury. - 0
Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes.	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 5	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 4	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 3	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 2	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 1	Effectively identify cases of cancer patients and survivors at risk of increased premature cardiovascular events, and identify optimal pharmacologic and lifestyle interventions to improve patient outcomes. - 0

Rate the following *

Scoring Key: 5=Excellent 4=Very Good 3=Good 2=Fair 1=Poor

	5	4	3	2	1
Course content.	Course content. - 5	Course content. - 4	Course content. - 3	Course content. - 2	Course content. - 1
Richard M. Steingart, M.D., FACC	Richard M. Steingart, M.D., FACC - 5	Richard M. Steingart, M.D., FACC - 4	Richard M. Steingart, M.D., FACC - 3	Richard M. Steingart, M.D., FACC - 2	Richard M. Steingart, M.D., FACC - 1

Was this course fair, balanced and without commercial bias? *

Yes

No

If you checked "No,” please explain why: *

How many patients will you see in your practice who will likely be impacted by what you learned at this activity? *

1-5

6-10

Over 10

Not applicable to my practice

What do you intend to do differently in the treatment of your patients as a result of what you learned? What new strategies will you apply in your practice of patient care? *

If you do not plan to implement any new strategies learned, please list any barriers or obstacles that might keep you from doing so. *

List topics related to this lecture that you want to learn more about?

Comments

Name

You are here

Miami Cardiac & Vascular Institute Grand Rounds Evaluation - April 19, 2017